Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) on Ethanol in Heavy Drinkers with PTSD - Outpatient Study
Latest Information Update: 05 Jun 2025
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Alcoholism; Post-traumatic stress disorders
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 31 May 2025 Planned initiation date changed from 28 Apr 2025 to 30 Jun 2025.
- 04 Apr 2025 Planned initiation date changed from 10 Mar 2025 to 28 Apr 2025.
- 04 Mar 2025 Planned initiation date changed from 14 Oct 2024 to 10 Mar 2025.